Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandros Spyridonidis

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|December 8, 2022
Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?Alexandros Spyridonidis
Blood|January 22, 2020
How I treat measurable (minimal) residual disease in acute leukemia after allogeneic hematopoietic cell transplantationAlexandros Spyridonidis
American Journal of Blood Research|July 5, 2012
A long road of T-cells to cure cancer: from adoptive immunotherapy with unspecific cellular products to donor lymphocyte infusions and transfer of engineered tumor-specific T-cellsAlexandros Spyridonidis, Maria Liga
International Journal of Molecular Sciences|February 28, 2013
DNA damage and repair in epithelium after allogeneic hematopoietic stem cell transplantationMaria Themeli, Alexandros Spyridonidis
Journal of Cancer Research and Clinical Oncology|January 17, 2004
Hematopoietic stem cell transplantation: more than just hematopoietic?Alexandros Spyridonidis, Roland Mertelsmann, Jürgen Finke
European Radiology|March 1, 2002
Imaging findings in the rare catastrophic variant of the primary antiphospholipid syndromeChristina Thuerl, Carsten Altehoefer, Alexandros Spyridonidis, et al.
Chimerism|May 7, 2011
DNA chimerism and its consequences after allogeneic hematopoietic cell transplantationMaria Themeli, Miguel Waterhouse, Juergen Finke, et al.
BMJ Case Reports|May 23, 2022
Tongue graft-versus-host disease: remission with ruxolitinibKaterina Grafanaki, Spyridon Lygeros, Alexandros Spyridonidis, et al.
Current Opinion in Immunology|March 11, 2026
Current role of ATG in GVHD prevention: optimizing post-transplantation outcomes through combination with PTCYMaria Liga, Dimitrios Tsokanas, Angeliki N Georgopoulou, et al.
Clinical Transplantation|May 10, 2005
Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Robert Zeiser, Ralph Wäsch, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|December 8, 2022
Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?Alexandros Spyridonidis
Blood|January 22, 2020
How I treat measurable (minimal) residual disease in acute leukemia after allogeneic hematopoietic cell transplantationAlexandros Spyridonidis
American Journal of Blood Research|July 5, 2012
A long road of T-cells to cure cancer: from adoptive immunotherapy with unspecific cellular products to donor lymphocyte infusions and transfer of engineered tumor-specific T-cellsAlexandros Spyridonidis, Maria Liga
International Journal of Molecular Sciences|February 28, 2013
DNA damage and repair in epithelium after allogeneic hematopoietic stem cell transplantationMaria Themeli, Alexandros Spyridonidis
Journal of Cancer Research and Clinical Oncology|January 17, 2004
Hematopoietic stem cell transplantation: more than just hematopoietic?Alexandros Spyridonidis, Roland Mertelsmann, Jürgen Finke
European Radiology|March 1, 2002
Imaging findings in the rare catastrophic variant of the primary antiphospholipid syndromeChristina Thuerl, Carsten Altehoefer, Alexandros Spyridonidis, et al.
Chimerism|May 7, 2011
DNA chimerism and its consequences after allogeneic hematopoietic cell transplantationMaria Themeli, Miguel Waterhouse, Juergen Finke, et al.
BMJ Case Reports|May 23, 2022
Tongue graft-versus-host disease: remission with ruxolitinibKaterina Grafanaki, Spyridon Lygeros, Alexandros Spyridonidis, et al.
Current Opinion in Immunology|March 11, 2026
Current role of ATG in GVHD prevention: optimizing post-transplantation outcomes through combination with PTCYMaria Liga, Dimitrios Tsokanas, Angeliki N Georgopoulou, et al.
Clinical Transplantation|May 10, 2005
Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Robert Zeiser, Ralph Wäsch, et al.
Pageof 11